Benjamin P. Haynes

664 total citations
14 papers, 530 citations indexed

About

Benjamin P. Haynes is a scholar working on Pharmacology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Benjamin P. Haynes has authored 14 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Genetics and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Benjamin P. Haynes's work include Estrogen and related hormone effects (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Hormonal and reproductive studies (3 papers). Benjamin P. Haynes is often cited by papers focused on Estrogen and related hormone effects (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Hormonal and reproductive studies (3 papers). Benjamin P. Haynes collaborates with scholars based in United Kingdom, United States and Germany. Benjamin P. Haynes's co-authors include Mitch Dowsett, Michael Jarman, Gerard A. Potter, S. Elaine Barrie, Phyllis M. Goddard, Iris B. Parr, Raymond McCague, Per Eystein Lønning, R. Charles Coombes and Leslie J. Griggs and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Benjamin P. Haynes

14 papers receiving 519 citations

Peers

Countries citing papers authored by Benjamin P. Haynes

Since Specialization

Citations

This map shows the geographic impact of Benjamin P. Haynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin P. Haynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin P. Haynes more than expected).

Fields of papers citing papers by Benjamin P. Haynes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin P. Haynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin P. Haynes. The network helps show where Benjamin P. Haynes may publish in the future.

Co-authorship network of co-authors of Benjamin P. Haynes

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin P. Haynes. A scholar is included among the top collaborators of Benjamin P. Haynes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin P. Haynes. Benjamin P. Haynes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	420P An exosome-based ESR1 monitoring RT-qPCR kit that rapidly and accurately detects acquired resistance variants at ≤ 0.1% frequency in liquid biopsy samples 2024 ·Annals of Oncology ·Sarah Statt, (unknown), Matt Church, Jeffrey L. Myers, H. H. Dale, (unknown), Kevin Kelnar, Benjamin P. Haynes	1
2	Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors 2014 ·European Journal of Cancer ·Per Eystein Lønning, Benjamin P. Haynes, Mitch Dowsett	28
3	Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039) 2014 ·Clinical Cancer Research ·Alexandra Léary, Abigail Evans, Stephen Johnston, Roger A’Hern, Judith M. Bliss, Rashmita Sahoo, Simone Detre, Benjamin P. Haynes, Margaret Hills, Catherine Harper‐Wynne, Nigel Bundred, Gill Coombes, Ian Smith, Mitch Dowsett	21
4	Intraocular penetration of tamoxifen13None of the authors have a proprietary interest in the medication or other therapy discussed in this manuscript. 2000 ·Ophthalmology ·Christina J. Flaxel, (unknown), Benjamin P. Haynes, Zdeněk Gregor	17
5	Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study. 1998 ·Journal of Clinical Oncology ·(unknown), Eugene H. Johnson, Corey J. Langer, Chandra P. Belani, Benjamin P. Haynes, Ron Greenberg, (unknown), (unknown), Wallace T. Miller, (unknown), (unknown), Jeanne Devin, Reinhard von Roemeling, Jean Viallet	55
6	Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P45017α inhibitors 1997 ·The Journal of Steroid Biochemistry and Molecular Biology ·S. Elaine Barrie, Benjamin P. Haynes, Gerard A. Potter, Florence Chan, Phyllis M. Goddard, Mitch Dowsett, Michael Jarman	26
7	3- and 4-Pyridylalkyl Adamantanecarboxylates: Inhibitors of Human Cytochrome P450₁₇_α (17α-Hydroxylase/C_17,20-Lyase). Potential Nonsteroidal Agents for the Treatment of Prostatic Cancer 1996 ·Journal of Medicinal Chemistry ·(unknown), Gerard A. Potter, S. Elaine Barrie, Benjamin P. Haynes, Martin Rowlands, (unknown), Michael Jarman	49
8	Idoxifene: report of a phase I study in patients with metastatic breast cancer. 1995 ·PubMed ·R. Charles Coombes, Benjamin P. Haynes, Mitch Dowsett, Michael Quigley, J English, (unknown), Leslie J. Griggs, (unknown), R. MCCAGUE, Michael Jarman	54
9	Pharmacology of novel steroidal inhibitors of cytochrome P45017 (17α-hydroxylase/C17–20 lyase) 1994 ·The Journal of Steroid Biochemistry and Molecular Biology ·S. Elaine Barrie, Gerard A. Potter, Phyllis M. Goddard, Benjamin P. Haynes, Mitch Dowsett, Michael Jarman	206
10	Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer 1991 ·Cancer Chemotherapy and Pharmacology ·Benjamin P. Haynes, Michael Jarman, Mitch Dowsett, (unknown), (unknown), Leslie J. Griggs, Alison Jones, Trevor J. Powles, Robert C. Stein, R. Charles Coombes	22
11	Metabolism of the 4-iodo derivative of tamoxifen by isolated rat hepatocytes 1990 ·Biochemical Pharmacology ·Raymond McCague, Iris B. Parr, Benjamin P. Haynes	29
12	Hepatic enzyme induction and vitamin K1 elimination in man 1987 ·European Journal of Clinical Pharmacology ·AK Scott, Benjamin P. Haynes, (unknown), E. E. Ohnhaus, B. K. Park	11
13	A study of factors which determine the pharmacological response to vitamin K in coumarin anticoagulated rabbits 1984 ·Biochemical Pharmacology ·(unknown), Benjamin P. Haynes, (unknown)	7
14	Stereoselectivity of catecholamines: differential effects of cocaine and desipramine on catecholamine-induced contractions of the rat isolated vas deferens 1983 ·Journal of Pharmacy and Pharmacology ·B K Park, Benjamin P. Haynes, Shelley Sheridan, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact